Quetzal Therapeutics

Biotechnology Research • 1 N Wacker Dr, Suite 1650, United States • 11-20 Employees

Company overview

Headquarters	1 N Wacker Dr, Suite 1650, Chicago, Illinois 60606, US
Website	quetzaltx.com
NAICS	541714
Keywords	Oncology, Rare Disease, Acute Promyelocytic Leukemia, Qtx-2101, Qtx-2102
Founded	2025
Employees	11-20

Key Contacts at Quetzal Therapeutics

Sridhar Desikan

Co-Founder, Chief Scientific Officer

Raymond Tam

Director Clinical Operations

Quetzal Therapeutics Email Formats

Quetzal Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@quetzaltx.com), used 77.8% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@quetzaltx.com	77.8%
{first initial}{last name}	jdoe@quetzaltx.com	22.2%

About Quetzal Therapeutics

Through cutting-edge science and pioneering innovation, we develop breakthrough therapies that improve patients’ lives. Our mission is to push the boundaries of treatment possibilities, delivering hope and life-changing solutions to those who need them most. Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL). The company plans to initiate Phase III clinical trials by late-2025, with enabling activities ongoing. Quetzal is also developing a pre-clinical asset QTX-2102, an advanced, next-generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity.

Quetzal Therapeutics revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,100,000
Total funding	No funding

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

Quetzal Therapeutics has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Quetzal Therapeutics has never raised funding before.

Frequently asked questions

Quetzal Therapeutics is located in 1 N Wacker Dr, Suite 1650, US.

Quetzal Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Quetzal Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Quetzal Therapeutics

Sridhar Desikan

Co-Founder, Chief Scientific Officer

Raymond Tam

Director Clinical Operations

4.8

40,000 users